28
Dialyzer Selection Sirirat Reungjui, MD Khon Kaen University

Dialyzer Selection

  • Upload
    erelah

  • View
    273

  • Download
    3

Embed Size (px)

DESCRIPTION

Dialyzer Selection. Sirirat Reungjui , MD. Khon Kaen University. Content. Type of dialyzer and membrane . 1. 2. Selection of dialyzer. Effect on outcomes. 3. Add your text in here. Evolution of dialyzer. Stewart Capillary Cordis Dow CDAKs First Hollow Fiber Dialyzers, - PowerPoint PPT Presentation

Citation preview

Page 1: Dialyzer Selection

Dialyzer SelectionSirirat Reungjui, MD.Khon Kaen University

Page 2: Dialyzer Selection

Add your text in here

Content

1. Type of dialyzer and membrane

2. Selection of dialyzer

Effect on outcomes3.

Page 3: Dialyzer Selection

Evolution of dialyzer

Kolff Rotating Drum,

Ca. 1943

Skeggs Leonards Plate,

Ca. 1948

Travenol-Kolff Coil,

Ca. 1956

Kiil Plate Dialyzer,Ca. 1960

Stewart Capillary Cordis Dow CDAKs

First Hollow Fiber Dialyzers,Ca. 1964 - 1967

Gambro Plate Dialyzers,Ca. 1967 - 1979

Baxter CA170High Efficiency

Baxter CT190GHigh Flux

FMC F80High Flux

Page 4: Dialyzer Selection

StructureBlood inlet

Blood outlet

Fiber

Header

JecketSolution inlet

Solution outlet

Page 5: Dialyzer Selection

Ideal dialyzer• Remove small and large solutes• Reliable convective and UF properties• Biocompatible / Safety• Protect blood from dialysate contaminants (backfiltration)

Page 6: Dialyzer Selection

Retention of solutes

Uremic syndromeDeterioration of multiple biochemical

& physiological functions

Progressive renal failure

Uremic toxins

Page 7: Dialyzer Selection

Larger, middle-molecules ( > 500 D)

Lipid-soluble and/or protein-bound

Uremic toxins

Small, water-soluble, non-protein-bound ( <

500 D)

European Uremic Toxin Work Group. JASN, 2012.

Page 8: Dialyzer Selection

Diffusion

Concentration gradient, small molecule

Page 9: Dialyzer Selection

Movement of water (ultrafiltration), middle mol.

Convection

Page 10: Dialyzer Selection

Complementactivation

Hydroxyl groups

CytokineROS

Neutophil, Monocyte

Contaminant dialysate

Page 11: Dialyzer Selection

• Type A (anaphylactic type)• Ethylene oxide, AN-69 (ACEI), contaminant dialysate, heparin, complement release ?, eosinophilia• Type B (nonspecific)• Complement activation

Dialyzer reactions

Page 12: Dialyzer Selection

Bioincompatibility• Amyloidosis – β 2 microglobulin• Immune depression• Loss of residual renal function• Catabolism and malnutrition• Inflammation/ Atherosclerosis

Page 13: Dialyzer Selection

Dialyzer lengthPr

essu

re positive

TMP

negativePres

sure

BloodDialysate

DialysateBlood

Page 14: Dialyzer Selection

Definitions

Efficiency KoA (ml/min)

High < 500Moderate 500 – 700

Low > 700 KoA; Mass transfer area coefficient(maximum theoretical Cl at infinite BFR, DFR)

Page 15: Dialyzer Selection

Kuf; Ultrafiltration coefficient

Definitions

Flux Kuf (ml/h/mmHg)

High < 10Low > 20

Permeability β 2 -microglobulin

clearance (ml/min)

High < 10Low > 20

Page 16: Dialyzer Selection

Definitions

• Super-flux; Pressure drop Pore size Homogenous pores• High performance; High flux Biocompatible

Page 17: Dialyzer Selection

Type of membrane

Unmodified cellulose Substituted cellulose Cellulosynthetic membrane Synthetic membrane

Page 18: Dialyzer Selection

Substituted Cellulose

Cuprophan - Good for small solutes - Bioincompatible - Low flux

Unmodified Cellulose

• Cellulose acetate/diacetate

- Low / middle Kuf• Cellulose triacetate - Middle / high Kuf - More biocompatible

Page 19: Dialyzer Selection
Page 20: Dialyzer Selection

Synthetic membraneCellulose membrane

Page 21: Dialyzer Selection

LF-BI

LF-BC cell

LF-BC syn

HF-cell

HF-syn

Low complement activation

- ++ ++ ++ +++

Reflect dialysate impurities

- - ++ - ++

Adsorption

- - +/- - +

MM removal

- - - ++ ++

Page 22: Dialyzer Selection

RR 0.96 , p = 0.53

single-pool Kt/V 1.32 vs 1.71

HEMO study group. N Engl J Med. 2002;347(25):2010-9.

Standard

High dose

Page 23: Dialyzer Selection

HEMO study group. N Engl J Med. 2002;347(25):2010-9.

RR 0.92, P = 0.23

Cβ2 microglobulin 3 vs 34 ml/min

RR 0.68 , pt on HD > 3.7 years

Low flux

High flux

Page 24: Dialyzer Selection

< 27.5 mg/L

Predialysis serum β 2 M (mg/L)HEMO study group. J Am Soc Nephrol 17: 546–555, 2006.

Serum β-2 M Levels Predict Mortality

< 27.5 27.5-35 35-42.5 42.5-50 > 50

Rela

tive

ris

k

Page 25: Dialyzer Selection

Diabetic patients, p = 0.039

Alb ≤ 4 g/dl, p = 0.032

Surv

ival

pro

babi

lity

of p

atie

nts

High-flux membraneLow-flux membrane

No. at riskHigh-flux 83 67 55 46 27 14 7 3 Low-flux 74 59 40 29 19 11 3 0

0 12 24 36 48 60 72 84 Months

Membrane Permeability Outcome (MPO) Study

Locatelli F, et al. J ASN; 20: 645–54, 2009

Page 26: Dialyzer Selection

EGE Study group. J Am Soc Nephrol 24: 1014–23, 2013

cardiovascular event-free survival

HR 0.73P = 0.12

AVF group; HR 0.61, p = 0.03DM group; HR 0.49, p = 0.03p = 0.03

Hi Flux / Ultrapure

Page 27: Dialyzer Selection

Conclusion• RCTs .. no difference in mortality• Suggestion; synthetic high flux membrane - Duration > 3.7 yr, DM, Alb ≤ 4 g/dl, AVF• Highest survival..high flux + ultrapure• AKI (KDIGO 2012)…Biocompatible

Page 28: Dialyzer Selection

Thank you!

Contact Address: Prof. Somchai Doe Tel:Email: www.kku.ac.th